Skip to main content
Publish date:

AIM ImmunoTech To Host Investor Update Webcast On Wednesday, July 14th At 11:00 AM ET

OCALA, Fla., July 06, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc.

OCALA, Fla., July 06, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it will host an investor update webcast at 11:00 a.m. Eastern Time on Wednesday, July 14, 2021, to discuss recent accomplishments and upcoming milestones. Investors and other interested parties are invited to submit questions to management prior to the call's start via email to

The webcast may be accessed at or on the Company's website at For those unable to participate at that time, a replay of the webcast will be available until Thursday, July 14, 2022 on the Company's website.

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.


Crescendo Communications, LLCPhone: 212-671-1021Email:

AIM ImmunoTech IncPhone: 800-778-4042Email: